ChemPartner PharmaTech Co Ltd (300149) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ChemPartner PharmaTech Co Ltd (300149) has a cash flow conversion efficiency ratio of 0.012x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥28.21 Million ≈ $4.13 Million USD) by net assets (CN¥2.37 Billion ≈ $347.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300149 equity financing ratio to measure how much of total assets are equity-financed.
ChemPartner PharmaTech Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how ChemPartner PharmaTech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of ChemPartner PharmaTech Co Ltd to evaluate the quality of earnings relative to operating cash generation.
ChemPartner PharmaTech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ChemPartner PharmaTech Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Arizona Sonoran Copper Company Inc
TO:ASCU
|
-0.001x |
|
Yesway, Inc. Class A Common Stock
NASDAQ:YSWY
|
-47546.000x |
|
Hanilcmt Co Ltd
KO:300720
|
0.053x |
|
Attacq
JSE:ATT
|
0.030x |
|
Zhejiang Zhongcheng Packing Material Co Ltd
SHE:002522
|
0.020x |
|
Invesco Municipal Opportunity Trust
NYSE:VMO
|
0.021x |
|
Ardmore Shipping Corporation
F:A61
|
0.041x |
|
LightPath Technologies Inc
NASDAQ:LPTH
|
-0.060x |
Annual Cash Flow Conversion Efficiency for ChemPartner PharmaTech Co Ltd (2007–2025)
The table below shows the annual cash flow conversion efficiency of ChemPartner PharmaTech Co Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see 300149 market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.30 Billion ≈ $190.28 Million |
CN¥190.50 Million ≈ $27.88 Million |
0.146x | +7.83% |
| 2024-12-31 | CN¥1.24 Billion ≈ $181.17 Million |
CN¥168.21 Million ≈ $24.61 Million |
0.136x | +31.45% |
| 2023-12-31 | CN¥1.46 Billion ≈ $213.77 Million |
CN¥150.99 Million ≈ $22.09 Million |
0.103x | -6.04% |
| 2022-12-31 | CN¥2.39 Billion ≈ $349.14 Million |
CN¥262.46 Million ≈ $38.41 Million |
0.110x | -42.15% |
| 2021-12-31 | CN¥1.99 Billion ≈ $291.06 Million |
CN¥378.22 Million ≈ $55.35 Million |
0.190x | +35.89% |
| 2020-12-31 | CN¥2.45 Billion ≈ $358.86 Million |
CN¥343.16 Million ≈ $50.22 Million |
0.140x | +49.86% |
| 2019-12-31 | CN¥2.30 Billion ≈ $337.05 Million |
CN¥215.07 Million ≈ $31.47 Million |
0.093x | -15.36% |
| 2018-12-31 | CN¥2.20 Billion ≈ $322.59 Million |
CN¥243.19 Million ≈ $35.59 Million |
0.110x | +45.29% |
| 2017-12-31 | CN¥835.45 Million ≈ $122.25 Million |
CN¥63.43 Million ≈ $9.28 Million |
0.076x | -17.96% |
| 2016-12-31 | CN¥769.93 Million ≈ $112.67 Million |
CN¥71.26 Million ≈ $10.43 Million |
0.093x | -33.47% |
| 2015-12-31 | CN¥723.81 Million ≈ $105.92 Million |
CN¥100.69 Million ≈ $14.73 Million |
0.139x | +62.47% |
| 2014-12-31 | CN¥696.53 Million ≈ $101.92 Million |
CN¥59.63 Million ≈ $8.73 Million |
0.086x | +23.89% |
| 2013-12-31 | CN¥670.29 Million ≈ $98.08 Million |
CN¥46.32 Million ≈ $6.78 Million |
0.069x | -19.60% |
| 2012-12-31 | CN¥640.90 Million ≈ $93.78 Million |
CN¥55.09 Million ≈ $8.06 Million |
0.086x | +350.62% |
| 2011-12-31 | CN¥611.46 Million ≈ $89.48 Million |
CN¥11.66 Million ≈ $1.71 Million |
0.019x | -47.63% |
| 2010-12-31 | CN¥571.30 Million ≈ $83.60 Million |
CN¥20.81 Million ≈ $3.05 Million |
0.036x | -72.23% |
| 2009-12-31 | CN¥101.26 Million ≈ $14.82 Million |
CN¥13.28 Million ≈ $1.94 Million |
0.131x | -64.72% |
| 2008-12-31 | CN¥58.36 Million ≈ $8.54 Million |
CN¥21.70 Million ≈ $3.18 Million |
0.372x | -59.35% |
| 2007-12-31 | CN¥24.25 Million ≈ $3.55 Million |
CN¥22.19 Million ≈ $3.25 Million |
0.915x | -- |
About ChemPartner PharmaTech Co Ltd
ChemPartner PharmaTech Co.,Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company operates in two segments, Microecological Nutrition and Medical Business; and Pharmaceutical Research and Development Service and Production Outsourcing Business. It offers prebiotic products and the provision of microecological medical services. The company provides comprehen… Read more